Popular Stories
- Arcutis Biotherapeutics (N
- Nexgel: Bringing Innovatio
- Ekso Bionics: Advancing Ra
- Esperion: Revolutionizing
- AMSC: Restructuring the Po
- Harrow Inc: Envisioning a
SAMPLE REPORTS
- Company Summary.pdf
- Daily Market Updates.pdf
- Initiating Coverage.pdf
- Investors' Presentation.pdf
- Portfolio Performance Analysis.pdf
- Pre-Result Analysis.pdf
- Result Review.pdf
- Short Initiating Coverage.pdf

Blurred vision Tag

  • All
  • Beauty
  • Biotechnology
  • Cannabis
  • Communications
  • Education
  • Energy
  • Entertainment
  • Environment
  • ETFs
  • Finance
  • Fitness
  • Food and Beverage
  • Healthcare
  • Hospitality
  • Insider Trading
  • Investing Ideas
  • Macro
  • Market Insight
  • Miscellaneous
  • Power
  • Real Estate
  • Retail
  • Sectors
  • Security
  • Startups
  • Technologies
  • Trending
  • Uncategorized
Can Cara Therapeutics buck the trend?

Cara Therapeutics (NASDAQ: CARA) recently posted its first quarter, 2019 results. The company reported a net loss of $22.0 million, or $0.56 per basic and diluted share compared to a net loss of $16.8 million, or $0.51 per basic and diluted share, for the first...

28 May, 2019 0 Comments
Emerging Therapeutics in Preeclampsia Management

Preeclampsia is a pregnancy related complication that affects over 5% to 8% of pregnancies or about 3,00,000 women in the US alone. An estimated 10,500 babies in the U.S, succumb to preeclampsia while others suffer from extensive damage owing to premature delivery. It is one of...

25 April, 2019 0 Comments
WordPress Video Lightbox Plugin